藏、蒙、维、傣医药治疗心肌缺血再灌注损伤概述  

Tibetan,Mongolian,Uygur and Dai Medicine Treatment of Myocardial Ischemia-reperfusion Injury Overview

作　　者：陈蓉[1] 陈清华[1] 李琼超 熊金富[1] 梁志庆 王仁杰[1] 吕仪 郑进[2] 

机构地区：[1]云南中医学院,云南昆明650500 [2]北京中医药大学,北京100029

出　　处：《中国民族民间医药》2017年第9期1-3,7,共4页Chinese Journal of Ethnomedicine and Ethnopharmacy

基　　金：基金项目:国家中医药管理局"十二五规划"傣医学重点学科

摘　　要：近几年,中医及西医对心肌缺血再灌注损伤研究较多,民族医药防治的研究报道较少。文章从藏、蒙、维、傣医药理论、方药应用、研究进展对其进行概述,以期为民族医药防治心肌缺血再灌注损伤有所启发。Recent years, Chinese medicine and Western medicine study the phenomenon more, Few studies have reported about ethinomedicine. This article will from the Tibetan, Mongolian, Uygur, Dai medicine theory, prescription application, research progress to view, which aim to inspire ethnic medicine to prevent and cure myocardial ischemia reperfusion injury.

关 键 词：藏医药 蒙医药 维医药 傣医药 心肌缺血再灌注损伤 

分 类 号：R29[医药卫生—民族医学]